---
title: "Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288440870.md"
description: "Lake Street analyst Frank Takkinen reiterated a Buy rating on ClearPoint Neuro (CLPT) with a $30.00 price target. This contrasts with the broader market consensus, which rates CLPT as a Strong Buy with an average price target of $22.00."
datetime: "2026-06-02T13:46:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288440870.md)
  - [en](https://longbridge.com/en/news/288440870.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288440870.md)
---

# Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on ClearPoint Neuro, with a price target of $30.00.

### Claim 55% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Takkinen covers the Healthcare sector, focusing on stocks such as Stereotaxis, TriSalus Life Sciences, and Adagio Medical Holdings. According to TipRanks, Takkinen has an average return of \-1.7% and a 39.43% success rate on recommended stocks.

Currently, the analyst consensus on ClearPoint Neuro is a Strong Buy with an average price target of $22.00.

### Related Stocks

- [CLPT.US](https://longbridge.com/en/quote/CLPT.US.md)
- [STXS.US](https://longbridge.com/en/quote/STXS.US.md)
- [TLSI.US](https://longbridge.com/en/quote/TLSI.US.md)
- [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md)
- [TLSIW.US](https://longbridge.com/en/quote/TLSIW.US.md)

## Related News & Research

- [Lake Street Sticks to Their Buy Rating for Natural Gas Services Group (NGS)](https://longbridge.com/en/news/289804366.md)
- [Deutsche Bank  Keeps Their Buy Rating on Sanofi (SNYNF)](https://longbridge.com/en/news/289749184.md)
- [Analyst Maintains Buy on Tenet Healthcare, Reaffirming Unchanged $254 Price Target Amid Favorable Risk-Reward Setup](https://longbridge.com/en/news/289779010.md)
- [Piper Sandler Keeps Their Buy Rating on Ocular Therapeutix (OCUL)](https://longbridge.com/en/news/289771127.md)
- [Copper Lake Resources Ltd. Engages ICP Securities Inc. for Automated Market Making Services | WTCZF Stock News](https://longbridge.com/en/news/290192408.md)